Pharmaids Pharma Stock: price and insider trades · India
Pharmaids Pharma: what insiders have been doing
This page follows insider dealings at Pharmaids Pharma as filed with SEBI (PIT + SAST). Between 8 November 2025 and 8 November 2026, 2 insiders published 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
With 2 filings in twelve months, the company is quieter than the median of 4 filings across the 1,984 companies we follow on the same exchange.
Insider buying of Pharmaids Pharma has been absent for the past year.
Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 17,291 shares0EquityGiftSEBI:1a7d2306c6cb89e28d85615848c8ca5325b3dc0c
- 17,291 shares0EquityGiftSEBI:55eacc7fa06c3d007bea7aa7be37ddb176fd0f41
2 of 2 declarations
About Pharmaids Pharma
Pharmaids Pharma is a company operating in the XBOM market, specializing in the pharmaceutical sector. It focuses on the development and distribution of innovative medical products.